TMS Impact on Cognitive Sequencing
Trial Summary
Yes, you will need to stop taking anxiolytic, antidepressant, neuroleptic, or sedative medications to participate in this trial.
Research shows that repetitive transcranial magnetic stimulation (rTMS) can influence cognitive tasks, such as improving working memory and modulating sequence learning, by targeting specific brain areas like the dorsolateral prefrontal cortex. This suggests that rTMS might be effective in enhancing cognitive sequencing by altering brain activity in targeted regions.
12345Transcranial magnetic stimulation (TMS) is generally considered safe, but it can cause seizures in rare cases and may have temporary effects on brain function. Most studies suggest that serious problems are unlikely, but further research is needed to fully understand all potential side effects.
678910This TMS treatment is unique because it uses non-invasive brain stimulation to specifically target cognitive sequencing tasks, allowing researchers to explore causal brain-behavior relationships and the timing of neural processes, unlike traditional treatments that may not provide such precise control over brain activity.
13111213Eligibility Criteria
This trial is for individuals aged 18-50 who can consent, have at least an 8-year education, speak English fluently, and are right-handed. It's not for those with recent drug use, cognitive impairments due to neurological disorders, psychiatric disorders including substance abuse, stroke history, MRI contraindications or visual deficits.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo TMS stimulation during sequence-demanding and non-sequence-demanding tasks, with brain activation measured via fMRI
Follow-up
Participants are monitored for safety and effectiveness after treatment